121Universal Tumor Screening in Colorectal Cancer: Role of MMR Immunohistochemistry for Lynch Syndrome and Early-Onset CRC.2026 · Europe PMC
122Immunotherapy combined with anti-angiogenic therapy, radiotherapy and chemotherapy for the treatment of giant pelvic osteosarcoma: A case report and literature review.2026 · Europe PMC
123TPRG-04 ETOP 19-21 USZ-STRIKE: IMMUNOTHERAPY OR TARGETED THERAPY WITH OR WITHOUT STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH BRAIN METASTASES FROM MELANOMA OR NON-SMALL CELL LUNG CANCER2026 · Europe PMC
124UTROSCT: a case report and scoping review of ultrasound features, with exploratory serum proteomic findings.2026 · Europe PMC
125Optimizing Precision Oncology: Structural Frameworks for Local MTB Integration and Outcome Assessment.2026 · Europe PMC
126Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.2026 · Europe PMC
127Prognostic significance of the C-reactive protein-to-lymphocyte ratio in patients with cancers.2026 · Europe PMC
129Plasma cell-CD8+ T cell co-enrichment distinguishes immunotherapy-responsive hepatocellular carcinoma subtypes.2026 · Europe PMC
131Extrachromosomal DNA in urothelial carcinoma: mechanisms and clinical applications.2026 · Europe PMC
132Artificial intelligence in cancer immunotherapy: current trends in predicting response and personalizing treatment.2026 · Europe PMC
133Bidirectional crosstalk between the nervous system and the tumour microenvironment: mechanisms, feedback loops and therapeutic opportunities.2026 · Europe PMC
134Patient-derived organoids for hepatobiliary cancers: Molecular mechanisms, translational applications and precision therapeutics.2026 · Europe PMC
135When Standard Craniospinal Irradiation Leads to Severe Brainstem Toxicity: A Morbidity and Mortality Case of Pineoblastoma in 22q11.2 Deletion Syndrome.2026 · Europe PMC
136Immunotherapy in triple-negative breast cancer: From molecular mechanisms to precision medicine-overcoming resistance and optimizing clinical outcomes.2026 · Europe PMC
137The 14-protein lung cancer signature: questions of prediction, specificity, and causality2026 · Europe PMC
138Definitive Interstitial Brachytherapy for Isolated Cutaneous Metastasis in Breast Cancer.2026 · Europe PMC
139Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer.2026 · Europe PMC
141Awakening antitumour immunity in the multimorbid host: a hypothesis coupling cryoablation-induced immunogenic cell death with multi-target Traditional Chinese Medicine.2026 · Europe PMC
142The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials.2026 · Europe PMC
143Barriers and Priorities for Immunotherapy Implementation in Advanced Gastric Cancer: Findings from a Two-Phase Qualitative Study.2026 · Europe PMC
144Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.2026 · Europe PMC
145Outcomes of combined lung cancer resection and lung volume reduction surgery in adults with severe emphysema; a systematic review and meta-analysis.2026 · Europe PMC
146Bioinformatic Identification and Experimental Validation of a Prognostic Transcriptional Signature Derived from Asparagine Metabolism-Related Genes in Breast Cancer.2026 · Europe PMC
147Pelvic schwannoma misdiagnosed as colorectal cancer metastasis and the corresponding diagnostic lessons: A report of two cases.2026 · Europe PMC
148Artificial intelligence in oncology: linking biological discovery to clinical utility.2026 · Europe PMC
149Enhancing Early Integration of Pediatric Palliative Care: Evaluating a Clinician-Based Versus Criteria-Based Referral Process in Pediatric Oncology.2026 · Europe PMC
150ITGB5 promotes immune escape in hepatocellular carcinoma by regulating PD-L1 through SETDB1/Hippo signaling pathway.2026 · Europe PMC
151Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis.2026 · Europe PMC
152Efficacy of S-1 Monotherapy for Salivary Duct Carcinoma With <i>MYC</i> Amplification.2026 · Europe PMC
153Systemic inflammation and prognosis in patients with RAS/BRAF wild-type metastatic colorectal cancer receiving anti-EGFR therapy: A real-world cohort study.2026 · Europe PMC
154Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS<sup>G12D</sup> mutations: a phase 1 trial.2026 · Europe PMC
156Case Report: Bilateral tonic-clonic seizures as initial presentation of Lhermitte–Duclos Disease and Cowden Syndrome2026 · Europe PMC
157Cancer without a map: Navigating cancer of unknown primary through molecular profiling.2026 · Europe PMC
158In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol.2026 · Europe PMC
159Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy in Lung Cancer and Lung Metastases: A Systematic Review.2026 · Europe PMC
160Targeted Anti-TF Antibody-Drug Conjugates in Advanced Cervical Cancer-Tisotumab Vedotin-Systematic Review.2026 · Europe PMC
161Clinical Impact of Germline Multigene Sequencing in Pediatric Cohorts with a Wide Spectrum of Neoplasms.2026 · Europe PMC
162Rare child primary intracranial sarcoma associated with DICER1 mutation: a case report and review of the literature.2026 · Europe PMC
163Weekly measurement of HMGB1 during neoadjuvant chemoradiotherapy in rectal cancer patients: correlations with MRI response and ctDNA.2026 · Europe PMC
164Navigating nutritional information while living with metastatic cancer: a qualitative study of patient experiences and needs.2026 · Europe PMC
165Fusobacterium nucleatum and response to treatment in colon and rectal cancer: a systematic review.2026 · Europe PMC
166CT radiomics-histopathological correlation for mediastinal lymph node staging in non-small cell lung cancer.2026 · Europe PMC
167Synchronous pure adrenal lipoma and clear cell renal cell carcinoma with sarcomatoid differentiation in a patient with a history of breast cancer: a case report.2026 · Europe PMC
168Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics.2026 · Europe PMC
169Real-world implementation of pertuzumab from 2013 to 2023 for de Novo HER2-positive metastatic breast cancer in the Netherlands: a population-based study.2026 · Europe PMC
170Blood-based tumor biomarkers: integrating biological layers and analytical strategies for precision cancer detection.2026 · Europe PMC
171Curative-intent stereotactic ablative body radiation, surgery, and systemic therapy in non-osseous oligometastatic breast cancer.2026 · Europe PMC
172Outcomes and Molecular Correlates of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.2026 · Europe PMC
173Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer.2026 · Europe PMC
174Personalised neoantigen vaccines for precision oncology in Southeast Asia: clinical opportunities, infrastructure challenges, and policy perspectives.2026 · Europe PMC
175Leptomeningeal metastasis from colon cancer: a case report and review of literature.2026 · Europe PMC
176Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.2026 · Europe PMC
177Exosome-Inspired Nanocarriers in Cancer Therapy: Bio-Derived Nanotechnology Meets Nano Drug Delivery.2026 · Europe PMC
179Prognostic value of a modified lymph node ratio for combined colorectal cancer tumour deposits: a population-based study.2026 · Europe PMC
180Investigation of a Prostate Cancer Radiation Response Signature in the Breast Cancer SweBCG91RT Randomized Trial.2026 · Europe PMC